This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-expectations: Archive
Stay Ahead of the Game With Tapestry (TPR) Q4 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Tapestry (TPR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
TPRPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q2 Potential of Nice (NICE): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Nice (NICE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
NICEPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unveiling Amcor (AMCR) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Amcor (AMCR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
AMCRNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Insights Into Applied Materials (AMAT) Q3: Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Applied Materials (AMAT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.
AMATPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Curious about Deere (DE) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Deere (DE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.
DEPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q2 Potential of Advance Auto Parts (AAP): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Advance Auto Parts (AAP) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
AAPNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Want Better Returns? Don't Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
ELNegative Net Change MNSTPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Analysts Estimate Flowers Foods (FLO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Flowers Foods (FLO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FLONegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
BitFuFu Inc. (FUFU) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BitFuFu Inc. (FUFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FUFUPositive Net Change CANPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Exploring Analyst Estimates for Red Robin (RRGB) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Red Robin (RRGB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
RRGBNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Kamada (KMDA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
KMDANegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q4 Potential of Coherent (COHR): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Coherent (COHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
COHRNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
What Analyst Projections for Key Metrics Reveal About Cisco (CSCO) Q4 Earnings
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Cisco (CSCO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
CSCOPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Countdown to Bally's (BALY) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Bally's (BALY) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
BALYPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ahead of CAE (CAE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of CAE (CAE) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CAENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of Fidelis Insurance (FIHL) Q2 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Fidelis Insurance (FIHL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
FIHLNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Countdown to Brinker International (EAT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Brinker International (EAT) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
EATPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With European Wax Center (EWCZ) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of European Wax Center (EWCZ) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
EWCZPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Seeking Clues to Globale Online (GLBE) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Globale Online (GLBE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
GLBENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of MSG Entertainment (MSGE) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of MSG Entertainment (MSGE) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
MSGEPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
How to Boost Your Portfolio with Top Retail and Wholesale Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
TJXPositive Net Change ROSTPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
NICEPositive Net Change QCOMPositive Net Change
earnings-esp earnings-expectations earnings-outlook
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
ADIPositive Net Change JBLPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Will Ontrak, Inc. (OTRK) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Ontrak (OTRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
SAB Biotherapeutics (SABS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SABSPositive Net Change ABSINegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate